METROVACESA SA financials
METROVACESA SA
959800ZQW44V5U3SEZ73 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €588.0M | €502.4M |
| Gross profit | €124.0M | €127.6M |
| Depreciation & amortisation | €3.3M | €3.2M |
| Operating profit (EBIT) | €73.4M | €74.2M |
| Finance costs | €37.3M | €26.4M |
| Profit before tax | €24.5M | -€16.5M |
| Income tax expense | €8.6M | €4.3M |
| Profit for the year | €15.9M | -€20.8M |
| — attributable to owners | €15.9M | -€20.8M |
| Total comprehensive income | €15.9M | -€20.8M |
| Cash flow statement | ||
| Net cash from operating activities | €95.0M | €32.2M |
| Net cash from investing activities | €39.5M | -€28.7M |
| Net cash from financing activities | -€144.3M | -€9.2M |
| Dividends paid | €104.6M | €100.0M |
| Repayments of borrowings | €341.1M | €359.9M |
| Net change in cash | -€9.9M | -€5.7M |
| Balance sheet | ||
| Total assets | €2.41B | €2.53B |
| Non-current assets | €388.1M | €395.6M |
| Property, plant & equipment | €3.8M | €4.6M |
| Current assets | €2.03B | €2.14B |
| Cash & equivalents | €186.4M | €196.3M |
| Total equity | €1.60B | €1.69B |
| Non-current liabilities | €309.9M | €292.0M |
| Current liabilities | €506.7M | €555.4M |
| Trade & other payables | €285.5M | €305.0M |
| Deferred tax liabilities | €10.7M | €8.3M |
| Derived metrics | ||
| Operating margin | 12.5% | 14.8% |
| Net margin | 2.7% | -4.1% |
| Return on equity | 1.0% | -1.2% |
| Cash conversion ratio | 5.98× | -1.55× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €57.5M | -€37.5M |
| Adjustments For Decrease Increase In Loans and Advances To Banks | -€2.8M | €41.9M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€13.7M | -€23.9M |
| Adjustments For Fair Value Gains Losses | €3.1M | €4.0M |
| Adjustments For Finance Costs | €37.3M | €26.4M |
| Adjustments For Increase Decrease In Other Liabilities | -€949.0K | -€2.1M |
| Adjustments For Interest Income | €7.0M | €1.3M |
| Adjustments For Provisions | €25.9M | €57.0M |
| Adjustments For Undistributed Profits of Associates | €686.0K | €5.8M |
| Advertising Expense | €6.3M | €5.7M |
| Cash Advances and Loans Made To Related Parties | €805.0K | €636.0K |
| Changes In Equity | -€104.3M | -€99.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | €0 | €0 |
| Comprehensive Income Attributable To Owners of Parent | €15.9M | -€20.8M |
| Cost of Merchandise Sold | €458.2M | €391.7M |
| Current Financial Liabilities | €145.8M | €204.8M |
| Current Provisions | €35.6M | €31.1M |
| Deferred Tax Assets | €79.2M | €76.0M |
| Dividends Recognised As Distributions To Owners of Parent | €104.6M | €100.0M |
| Equity and Liabilities | €2.41B | €2.53B |
| Finance Income | €7.4M | €2.2M |
| Gain Loss Arising From Derecognition of Financial Assets Measured At Amortised Cost | -€3.1M | -€4.0M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €28.6M | €61.9M |
| Income Taxes Paid Refund Classified As Operating Activities | -€809.0K | -€3.0M |
| Increase Decrease Through Change In Equity of Subsidiaries | — | €49.0K |
| Increase Decrease Through Treasury Share Transactions | €267.0K | €577.0K |
| Inventories Total | €1.74B | €1.83B |
| Investment Property | €240.2M | €238.9M |
| Investments In Subsidiaries Joint Ventures and Associates | €49.1M | €49.0M |
| Issued Capital | €1.09B | €1.09B |
| Liabilities | €816.6M | €847.4M |
| Noncurrent Financial Liabilities | €248.3M | €233.6M |
| Noncurrent Payables | €43.4M | €35.5M |
| Noncurrent Provisions | €7.5M | €14.5M |
| Noncurrent Receivables | €15.7M | €27.1M |
| Other Comprehensive Income | €0 | €0 |
| Other Comprehensive Income Before Tax Gains Losses On Hedging Instruments That Hedge Investments In Equity Instruments | €0 | €0 |
| Other Current Assets | €10.5M | €19.5M |
| Other Current Liabilities | €39.8M | €14.5M |
| Other Equity Interest | €12.9M | €12.9M |
| Other Expense By Nature | €9.4M | €8.6M |
| Other Financial Assets | €25.8M | €52.2M |
| Other Gains Losses | -€71.5M | -€67.1M |
| Other Operating Income Expense | €3.1M | -€1.1M |
| Proceeds From Current Borrowings | €300.1M | €433.2M |
| Proceeds From Issue of Bonds Notes and Debentures | €102.7M | €135.0M |
| Profit Loss From Continuing Operations | €15.9M | -€20.8M |
| Repayments of Bonds Notes and Debentures | €102.0M | €118.4M |
| Repayments of Current Borrowings | €0 | €0 |
| Retained Earnings | -€261.1M | -€277.0M |
| Revenue From Sale of Goods | €65.7M | €84.1M |
| Sales and Marketing Expense | €9.8M | €9.2M |
| Services Expense | €9.2M | €10.1M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | -€686.0K | -€5.8M |
| Share Premium | €752.2M | €856.8M |
| Shortterm Employee Benefits Expense | €18.9M | €18.9M |
| Statutory Reserve | €1.8M | €1.8M |
| Trade and Other Receivables | €62.7M | €43.2M |
| Treasury Shares | €1.2M | €1.7M |
| Writedowns Reversals of Property Plant and Equipment | €2.6M | €5.0M |
Every line item above is a fact tagged in METROVACESA SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.